MLYS: SEC Form 4 filed by Mineralys Therapeutics Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for MLYS
Across the 29 sessions after earlier MLYS headlines, the stock closed higher 12 times and lower 17 times, with a median move of 2.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | MLYS | SPY |
|---|---|---|---|
| Oct 20, 2026 | Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats | +3.2% | +0.3% |
| Oct 12, 2026 | UBS initiated coverage on Mineralys Therapeutics with a new price target | -4.9% | -0.1% |
| Oct 9, 2026 | Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026 | +4.4% | +0.6% |
| Oct 5, 2026 | Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026 | -1.4% | +0.7% |
| Oct 2, 2026 | Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026 | -0.4% | +0.7% |
| Sep 30, 2026 | Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | +2.7% | -0.2% |
Earlier insider filings at MLYS
- Oct 2, 2026Chief Executive Officer Congleton Jon sold $1,909,665 worth of shares (75,000 units at $25.46) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 528,621 units (SEC Form 4)
- Sep 25, 2026Director Slingsby Brian Taylor sold $3,005,303 worth of shares (104,320 units at $28.81) (SEC Form 4)
- Sep 22, 2026Chief Commercial Officer Warren Eric exercised 7,438 shares at a strike of $13.24 and sold $209,136 worth of shares (7,438 units at $28.12) as part of a pre-agreed trading plan (SEC Form 4)
- Sep 17, 2026Director Karydas Daphne exercised 3,000 shares at a strike of $12.02 and sold $85,740 worth of shares (3,000 units at $28.58) as part of a pre-agreed trading plan (SEC Form 4)
- Aug 25, 2026Chief Commercial Officer Warren Eric exercised 7,437 shares at a strike of $13.24 and sold $193,189 worth of shares (7,437 units at $25.98) as part of a pre-agreed trading plan (SEC Form 4)
Quantisnow market dataNASDAQ
MLYS
Mineralys Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2023
Get push alerts for MLYS
Full MLYS profile on Quantisnow Follow MLYS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time